Survivorship care plans: are randomized controlled trials assessing outcomes that are relevant to stakeholders?

ConclusionsRCTs of SCPs ’ effectiveness have not assessed outcomes that stakeholders expect. To better understand SCPs’ effectiveness, future RCTs should assess outcomes of SCP use that are relevant from the perspective of multiple stakeholders.Implications for Cancer SurvivorsSCPs ’ effectiveness may be optimized when used with an eye toward outcomes that stakeholders expect from SCPs. For survivors, this means using SCPs as a map to guide them with respect to what kind of follow-up care they should seek, when they should seek it, and from whom they should seek it.
Source: Journal of Cancer Survivorship - Category: Cancer & Oncology Source Type: research